Cargando…
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is a prevalent urinary malignancy. Despite the recent development of better diagnostic tools and therapy, the five-year survival rate for individuals with advanced and metastatic ccRCC remains dismal. Unfortunately, ccRCC is less susceptible to radiation and c...
Autores principales: | Li, Qinyu, Xiao, Xueyan, Chen, Bingliang, Song, Guoda, Zeng, Kai, Li, Beining, Miao, Jianping, Liu, Chaofan, Luan, Yang, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597358/ https://www.ncbi.nlm.nih.gov/pubmed/36313627 http://dx.doi.org/10.3389/fonc.2022.964838 |
Ejemplares similares
-
Identification of a Gene Signature to Aid Treatment Decisions by Integrated Analysis of Mutated Genes Between Primary and Metastatic Prostate Cancer
por: Li, Qinyu, et al.
Publicado: (2022) -
Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma
por: Zeng, Kai, et al.
Publicado: (2022) -
A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
por: Liu, Hongxiang, et al.
Publicado: (2023) -
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer
por: Li, Qinyu, et al.
Publicado: (2022) -
Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
por: Li, Rong, et al.
Publicado: (2023)